Sign in

CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company

Passage BIO, Inc.

Sign in to watch
Ticker
PASG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822729751
Phone
2678660312
Business address
ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-03-03 Frazier Life Sciences IX, L.P. 10% owner Purchase +550,000 $18.00 $9.9M 5,009,219
2020-03-03 Frazier Life Sciences IX, L.P. 10% owner Conversion · Series A-1 Preferred Stock −2,977,242 0
2020-03-03 Frazier Life Sciences IX, L.P. 10% owner Conversion · Series A-2 Preferred Stock −1,049,175 0
2020-03-03 Frazier Life Sciences IX, L.P. 10% owner Conversion · Series B Preferred Stock −432,802 0
2020-03-03 Woiwode Thomas Director Conversion +2,977,242 2,977,242
2020-03-03 Woiwode Thomas Director Conversion +1,049,175 4,026,417
2020-03-03 Woiwode Thomas Director Conversion +708,352 708,352
2020-03-03 Woiwode Thomas Director Purchase +225,000 $18.00 $4.0M 933,352
2020-03-03 Woiwode Thomas Director Conversion · Series A-1 Preferred Stock −2,977,242 0
2020-03-03 Woiwode Thomas Director Conversion · Series A-2 Preferred Stock −1,049,175 0
2020-03-03 Woiwode Thomas Director Conversion · Series B Preferred Stock −708,352 0
2020-03-03 Heron Patrick J Director Conversion +2,977,242 2,977,242
2020-03-03 Heron Patrick J Director Conversion +1,049,175 4,026,417
2020-03-03 Heron Patrick J Director Conversion +432,802 4,459,219
2020-03-03 Heron Patrick J Director Purchase +550,000 $18.00 $9.9M 5,009,219
2020-03-03 Heron Patrick J Director Conversion · Series A-1 Preferred Stock −2,977,242 0
2020-03-03 Heron Patrick J Director Conversion · Series A-2 Preferred Stock −1,049,175 0
2020-03-03 Heron Patrick J Director Conversion · Series B Preferred Stock −432,802 0
2020-03-03 Yamada Tadataka Director Purchase +6,500 $18.00 $117K 656,149
2020-03-03 Ratcliffe Liam Director Purchase +2,800 $18.00 $50K 2,800

Page 12 of 14 · 264 trades